News and Updates

Explore the Latest from Sensus Healthcare

Discover the latest top news articles from Sensus Healthcare. Stay informed about our groundbreaking advancements, treatment breakthroughs, and industry insights. Explore our curated selection of articles and navigate through them using the pagination feature below

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

Superficial Radiotherapy: The Perfect Option for Treating Keloids

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Why You Should Choose SRT to Treat Your Squamous Cell Carcinoma

The Benefits of Superficial Radiotherapy (SRT)

Basal cell carcinoma versus squamous cell carcinoma

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.